After A -3.25% Drop In The Last Week, Does Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Still Make Sense To Buy?
During the recent session, Arcutis Biotherapeutics Inc (NASDAQ:ARQT)’s traded shares were 0.45 million, with the beta value of the company hitting 1.29. At the last